Influence of hydroxy ethyl starch infusion on serum bilirubin levels in cirrhotic patients treated with artificial liver support

International Journal of Artificial Organs

Volumn 25, Issue 10, 2002, Pages 918-922

  Kramer, Ludwig ^a   Bauer, E ^a   Gendo, A ^a   Madl, C ^a   Gangl, A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Artificial liver support; Bilirubin; Colloids; Confounding; Detoxification; HES; Jaundice

Indexed keywords

BODY FLUIDS; COLLOIDS; PATIENT MONITORING; STARCH;

ARTIFICIAL LIVER; ARTIFICIAL LIVER SUPPORT; BILIRUBIN; CONFOUNDING; ETHYL STARCH; HES; JAUNDICE; SERUM BILIRUBIN; STARCH SOLUTIONS; SUPPORT SYSTEMS;

DETOXIFICATION;

BILIRUBIN; CREATININE; HETASTARCH; POTASSIUM; SODIUM;

ADULT; ARTICLE; ARTIFICIAL LIVER; BILIRUBIN BLOOD LEVEL; BLOOD VOLUME; CLINICAL ARTICLE; CLINICAL TRIAL; COLLOID; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETOXIFICATION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG INFUSION; DRUG TOLERABILITY; EXTRACORPOREAL CIRCULATION; FEMALE; HEMODIALYSIS; HUMAN; HYPERBILIRUBINEMIA; HYPOTHESIS; JAUNDICE; LIVER CIRRHOSIS; MALE; NORMAL VALUE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 0036816201     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880202501004     Document Type: Article

References (21)

1. Turcotte JG, Wallin WV Jr, Child CG III. End to side versus side to side portacaval shunts in patients with hepatic cirrhosis. Am J Surg 1969; 117: 108-16.
2. O'Grady JG, Schalm SW, Williams R. Acute liver failure: Redefining the syndromes. Lancet 1993; 342: 273-5.
3. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
4. Mitzner SR, Stange J, Klammt S, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6: 277-86.
5. Ash SR, Steczko J, Knab WR, et al. Push-pull sorbent-based pheresis and hemodiabsorption in the treatment of hepatic failure: Preliminary results of a clinical trial with the BioLogic-DTPF System. Ther Apher 2000; 4: 218-28.
6. Chen SC, Hewitt WR, Watanabe FD, et al. Clinical experience with a porcine hepatocyte-based liver support system. Int J Artif Organs 1996; 19: 664-9.
7. Borie DC, Eyraud D, Boleslawski E, et al. Functional metabolic characteristics of intact pig livers during prolonged extracorporeal perfusion: Potential for a unique biological liver-assist device. Transplantation 2001; 72: 393-405.
8. Guevara M, Ginès P, Fernandez-Esparrach G, et al. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 1998; 27: 35-41.
9. Arroyo V, Ginès P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996; 23: 164-76.
10. Falkenhagen D, Strobl W, Vogt G, et al. Fractionated plasma separation and adsorption system: A novel system for blood purification to remove albumin bound substances. Artif Organs 1999; 23: 81-6.
11. Kramer L, Gendo A, Madl C, et al. A controlled study of sorbent suspension dialysis in chronic liver disease and hepatic encephalopathy. Int J Artif Organs 2001; 24: 434-42.
12. Ginès A, Escorsell A, Ginès P, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993; 105: 229-36.
13. Ferenci P, Müller C. Hepatic encephalopathy: Treatment. In: Burroughs A, Feagan B, McDonald JWB, eds. Evidence Based Gastroenterology; London: BMJ Books, 1999: pp. 443-55.
14. Hughes RD, Williams R. Use of bioartificial and artificial liver support devices. Semin Liver Dis 1996; 16: 435-44.
15. Stange J, Mitzner SR, Klammt S, et al. Liver support by extracorporeal blood purification: A clinical observation. Liver Transpl 2000; 6: 603-13.
16. Mitzner SR, Klammt S, Peszynski P, et al. Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system. Ther Apher 2001; 5: 417-22.
17. Tiribelli C, Ostrow JD. New concepts in bilirubin and jaundice: Report of the Third International Bilirubin Workshop, April 6-8, 1995, Trieste, Italy. Hepatology 1996; 24: 1296-311.
18. Galbraight RA, Drummond GS, Kappas A. Suppression of bilirubin production in the Crigler-Najjar type I syndrome: Studies with the heme oxygenase inhibitor, Sn-mesoporphyrin. Pediatrics 1992; 89: 175-82.
19. Chalasani N, Roy Chowdhury N, Roy Chowdhury J, Boyer TD. Kernicterus in an adult who is heterocygous for Crigler-Najjar syndrome and homozygous for the Gilbert-type genetic defect. Gastroenterology 1997; 112: 2099-103.
20. Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 1999; 29: 648-6.
21. Blei AT, Olafsson SM, Therrien G, Butterworth R. Ammonia-induced cerebral edema and intracranial hypertension in rats after portocaval anastomosis. Hepatology 1994; 19: 80-7.